Omnicell (NASDAQ:OMCL) Releases Q2 Earnings Guidance

Omnicell (NASDAQ:OMCL) updated its second quarter earnings guidance on Thursday. The company provided EPS guidance of $0.10-0.20 for the period, compared to the consensus EPS estimate of $0.27. The company issued revenue guidance of $250-260 million, compared to the consensus revenue estimate of $261.84 million. Omnicell also updated its FY24 guidance to $0.90-1.40 EPS.

Analysts Set New Price Targets

Several brokerages have weighed in on OMCL. Benchmark reiterated a buy rating and issued a $38.00 target price on shares of Omnicell in a report on Tuesday, April 30th. Wells Fargo & Company lowered their target price on Omnicell from $28.00 to $26.00 and set an equal weight rating for the company in a report on Friday, February 9th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of Hold and a consensus price target of $42.20.

Omnicell Price Performance

Shares of NASDAQ OMCL opened at $30.13 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.22 and a current ratio of 2.38. Omnicell has a 1-year low of $25.69 and a 1-year high of $77.14. The business has a fifty day moving average price of $27.73 and a 200 day moving average price of $31.72.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings data on Thursday, February 8th. The company reported $0.12 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.22. The firm had revenue of $258.85 million during the quarter, compared to analysts’ expectations of $256.00 million. Omnicell had a positive return on equity of 2.41% and a negative net margin of 1.91%. Research analysts anticipate that Omnicell will post 0.09 earnings per share for the current fiscal year.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.